Qiru Tian1
Yi Song
Yan Deng
Shike Lin- 1Hainan Vocational University of Science and Technology, Haikou, China
- 2Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China
- 3Office of Science and Technology, Youjiang Medical University for Nationalities, Baise, Guangxi, China
- 4Faculty of Nursing, Youjiang Medical University for Nationalities, Baise, Guangxi, China
- 5Department of Obstetrics and Gynaecology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China
A Correction on
Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis
By Tian Q, Song Y, Deng Y and Lin S (2025) Front. Endocrinol. 16:1593134. doi: 10.3389/fendo.2025.1593134
Affiliation “1Hainan Vocational University of Science and Technology, Haikou, China” was erroneously given as “1 School of Basic Medical Sciences, Hainan Vocational University of Science and Technology, Haikou, China”.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: tirzepatide, weight loss, meta-analysis, obesity, type 2 diabetes, adverse events
Citation: Tian Q, Song Y, Deng Y and Lin S (2025) Correction: Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis. Front. Endocrinol. 16:1683829. doi: 10.3389/fendo.2025.1683829
Received: 11 August 2025; Accepted: 15 August 2025;
Published: 25 August 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Tian, Song, Deng and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shike Lin, bGluc2hpa2VAeW11bi5lZHUuY24=; Yan Deng, c2hpcmxseUBjdWhrLmVkdS5oaw==